HIV-Associated Lipodystrophy Syndrome Clinical Trial
Official title:
Psychological Morbidity and Facial Volume in HIV Lipodystrophy:
The hypotheses of this study were that:
1. HIV lipodystrophy is associated with psychological morbidity relating to body image,
anxiety and depression.
2. Treatment of HIV lipodystrophy using autologous fat transfer, polylactic acid or
Bio-alcamid, is associated with an improvement in psychological morbidity and
anatomical volume of treated areas.
3. The DI3D system is a valid and reproducible method of recording and measuring facial
3-D volume.
as above ;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04340388 -
Contribution of Dolutegravir to Obesity and Cardiovascular Disease
|
Phase 4 | |
| Completed |
NCT00069004 -
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
|
N/A | |
| Terminated |
NCT00122668 -
Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients
|
Phase 4 | |
| Completed |
NCT01848340 -
An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects
|
Phase 1 | |
| Not yet recruiting |
NCT00662181 -
Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
|
N/A | |
| Completed |
NCT00130286 -
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT00135460 -
Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients
|
Phase 4 | |
| Completed |
NCT00135356 -
Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome
|
Phase 4 | |
| Active, not recruiting |
NCT00122226 -
MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
|
Phase 4 | |
| Completed |
NCT00646984 -
Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
|
Phase 4 | |
| Completed |
NCT00192660 -
HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)
|
Phase 4 | |
| Terminated |
NCT00148850 -
Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients
|
Phase 3 | |
| Completed |
NCT00383734 -
Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE
|
Phase 3 |